Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Ductal, Lobular, and Medullary

Explore clinical trials studying Neoplasms, Ductal, Lobular, and Medullary. Study availability and eligibility vary by location and protocol.

477 public trials 97 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Ductal, Lobular, and Medullary trial results

Completed

Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer

NCT02636582

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Ductal Carcinoma in Situ, +7 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

NCT02231723

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +17 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Parkview Research Center Fort Wayne, Indiana, United States
  • Indiana University Health Goshen Center for Cancer Care Goshen, Indiana, United States
View Trial Details
Completed

Recurrence After Whipple's (RAW) Study

NCT04596865

Conditions
Adenocarcinoma, Ampullary Cancer, Bile Duct Cancer, +35 more
Locations
  • Monash Medical Centre Clayton, Victoria, Australia
  • Medical University Innsbruck, Anichstr. 35 A Innsbruck, Austria
  • Azienda Ospedaliero - Universitaria Di Sassari Sassari, Sardinia, Italy
  • Azienda Ospedaliero - Universitaria Policlinico Umberto I Rome, Italy
View all 29 locations
View Trial Details
Completed

A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma

NCT02993731

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Ductal, +12 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Clearview Cancer Institute (CCI) Huntsville, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
View all 267 locations
View Trial Details
Completed

Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors

NCT03780517

Conditions
Adenocarcinoma, Advanced Nonhaematologic Malignancies, Bronchial Neoplasms, +27 more
Locations
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Institut Jules Bordet Brussels, Belgium
  • UZ Leuven Leuven, Belgium
View all 21 locations
View Trial Details
Completed

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer

NCT00666731

Conditions
Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +15 more
Locations
  • Penrose Cancer Center Colorado Springs, Colorado, United States
  • Centura - Porter Adventist Hospital Denver, Colorado, United States
  • Centura - St. Anthony Hospital Lakewood, Colorado, United States
  • Centura - Parker Adventist Hospital Parker, Colorado, United States
View all 65 locations
View Trial Details

Related conditions